Thèses de doctorat
Else Balke - Septembre 2018
Gene polymorphisms and clinical outcome at various stages of (pre)type 1 diabetes
Olivier Costa - Février 2017
Development of advanced immunoassyas for subpicomolar detection of plasma GAD65 as biomarker of beta cell destruction
Annelien Van Dalem - Mars 2017
Minimally-invasive measurements of beta cell function in (pre)type 1 diabetes
Simke Demeester - Juin 2016
Biomarkers to predict functional outcome to beta cell therapy trials in type 1 diabetes
Eric Balti Vounsia - Juin 2015
Biological prediction of rapid progression to type 1 diabetes: Preparing for immune intervention trials in the preclinical disease phase
Milca Asanghanwa – Juin 2014
Biomarkers in diabetes patients under age 40: comparison between Cameroon and Belgium
Eric Mbunwe – Octobre 2013
Contribution of screening for HLA class I alleles in prediction of type 1 diabetes in risk groups
Farah van Genderen – Juin 2013
Multiplex and species-specific immunoassays for measuring beta cell peptides in experimental and clinical studies
Ilse Vermeulen - Juin 2012
Refining the diagnostic armamentarium for classification and prediction of type 1 diabetes
Robert Hilbrands - Mai 2012
Immune monitoring in type 1 diabetic recipients of defined beta cell grafts: contribution to assess clinical outcome
Evy Vandemeulebroucke - Février 2011
Preservation of functional beta cell mass, assessed by hyperglycemic clamp, in human type 1 diabetes
Folefac Aminkeng – Septembre 2010
Refining the immunogenetic rik assessment for type 1 diabetes in the Belgian population
Jan Van Autreve - Juillet 2008
Study of genetic markers for type 1 diabetes within and outside the HLA region in the Belgian population
Inge Truyen - Décembre 2007
Identification of prediabetes in first degree relatives of type 1 diabetic probands
Katelijn Decochez - Mai 2005
Prediction of beta cell loss by islet autoantibodies: implications for prevention trials in humans
Ilse Weets - Février 2004
Ethiological and phenotypical heterogeneity of diabetes presenting before age 40 according to demographic and biological parameters: variable contribution of genetic and external factors
Christophe De Block - Mai 2002
Clinical significance of parietal cell antibodies with regard to manifestation of autoimmune gastropathy in type 1 diabetic patients
Bart Van der Auwera - Mars 1999
HLA and non-HLA genes in insulin-dependent diabetes mellitus. Contribution to a refined immunogenetic risk assessment.
Christina Vandewalle - Mars 1998
Epidemiology, clinical aspects and early biological markers of new-onset IDDM patients (0-39 years): the importance of diabetes registries for preventive health care strategies.
